オプションチェーンは、Uniti Groupの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Uniti Groupの市場センチメントを評価します。.

Uniti Group (NASDAQ:UNIT) 株価情報, オプションチェーン

Uniti Group

Uniti is a REIT with about 140,000 route miles of fiber in the us, primarily in the Southeast. It has agreed to merge with Windstream, which will result in Uniti giving up its REIT status and adding a consumer telecom business line. Uniti's business currently consists exclusively of fiber leasing to enterprises. Windstream currently leases the Uniti network and makes up the bulk of Uniti's revenue and profits. The combined firm will own 217,000 route miles of fiber and pass 4.3 million households and 150,000 commercial buildings, mostly in less populated markets in the Southeast. The firm will continue to offer fiber access to enterprises, as Uniti currently does, but residential telecom services will become its largest revenue stream.

Uniti Group Inc

UNITE Group PLC

UNITED BULLION EXCH INC by United Bullion Exchange, Inc.

UNITED CORPS LTD by United Corporations Limited

UNITED E&P INC by United E & P, Inc.

UNITED Inc

UNITED OIL & GAS PLC by UNITED OIL & GAS PLC

UNITED PALM OIL INDST PCL by United Palm Oil Industry Public Co Ltd

UNITED WORLD HLDG GRP LTD by United World Holding Group Ltd.

Unit Corp

United Airlines Holdings, Inc. - Common Stock

United Airlines Holdings Inc

UNITED AMERICAN CORP by United American Corp.

United American Corp

UNITED AMER HEALTHCARE CP by United American Healthcare Corp.

United American Healthcare Corp

UNITED AMERICAN PETR by United American Petroleum Corp.

United American Petroleum Corp

United Arrows Ltd

UNITED ARROWS UNSP/ADR by United Arrows Ltd.

United Bancorp Inc

UNITED BNCRP OF AL INC A by United Bancorporation of Alabama, Inc.

United Bancorp Of Alabama Inc

UNITED BNCSHS CLMBUS GRVE by United Bancshares, Inc.

United Bancshares Inc

UNITED BANK LTD GDR 144A by United Bank Ltd.

United Bank Ltd

United Bankshares Inc

Compania Cervecerias Unidas, S.A. Common Stock

United Breweries Co Inc

United Communications Partners Inc

United Community Banks, Inc. Depositary Shares, each representing 1/1000th interest in a share of Series I Non-Cumulative Preferred Stock

United Community Banks Inc

United Community Banks, Inc. Common Stock

UNITED CONSORTIUM LTD by United Consortium Ltd.

United Consortium Ltd

UNITED ENERGY CRP NEV by United Energy Corp.

United Energy Corp

UNITED ENERGY GRP LTD ORD by United Energy Group, Ltd.

United Energy Group Ltd

United Ethanol LLC

United Fire Group Inc

United Hampshire US REIT

UNITED HEALTH PRODUTS INC by United Health Products, Inc.

United Health Products Inc

United Homes Group, Inc - Class A Common Stock

United Homes Group Inc

UNITED INTERNET AG&CO REG by United Internet AG

United Internet AG

UNITED INTERNET UNSP/ADR by United Internet AG

UNITED LABS INTL HLDG ORD by United Laboratories International Holdings Ltd.

United Laboratories International Holdings Ltd

UNITED LITHIUM CORP by United Lithium Corp.

United Lithium Corp

United Malt Group Ltd Ordinary Shares

United Maritime Corporation - Common Stock

United Maritime Corp

United Microelectronics Corporation (NEW) Common Stock

United Microelectronics Corp

UNITED NATL BK CAIRO GA by United National Bank (Cairo, GA)

United National Bank

United Natural Foods Inc

UNITED OVRSEAS BK S/ADR by United Overseas Bank Ltd.

United Overseas Bank Ltd

UNITED OVERSEAS BANK ORD by United Overseas Bank Ltd.

United Parcel Service Inc

United Parks & Resorts Inc

UNITED PLANT BERHAD ORD by United Plantations Berhad

United Plantation Bhd

United Rail Inc

United Rentals Inc

UNITED RES HLDGS GRP INC by United Resource Holdings Group, Inc.

United Resources Holdings Group Inc

UNITED ROYALE HLDGS CORP by United Royale Holdings Corp.

United Royale Holdings Corp

United Security Bancshares - Common Stock

United Security Bancshares

United States 12 Month Natural Gas Fund

United States 12 Month Oil

United States Antimony Corporation Common Stock

United States Antimony Corp

United States Basketball League Inc

United States Brent Oil Fund, LP ETV

United States Cellular Corporation Common Stock

United States Cellular Corp

United States Cellular Corporation 5.500% Senior Notes due 2070

United States Cellular Corporation 6.250% Senior Notes due 2069

United States Commodity Index Fund ETV

United States Copper Index Fund ETV

United States Gasoline Fund LP

United States Lime & Minerals, Inc. - Common Stock

United States Lime & Minerals Inc

United States Natural Gas Fund LP

United States Oil Fund

United States Steel Corporation Common Stock

United States Steel Corp

UNITED SUPER MKTS HLDGS by UNITED SUPER MKTS HLDGS INC.

United Super Markets Holdings Inc

UNITED TENNESSEE BNKSHS by United Tennessee Bankshares, Inc.

United Tennessee Bankshares Inc

United Therapeutics Corporation - Common Stock

United Therapeutics Corp

UNITED URBAN INVT CORP by United Urban Investment Corp.

United Urban Investment Corp

UNITED UTIL GRP S/ADR PLC by United Utilities Group PLC

United Utilities Group PLC

UNITED UTILITIES GRP ORD by United Utilities Group PLC

United-Guardian Inc

UnitedHealth Group Incorporated Common Stock (DE)

UnitedHealth Group Inc

Unitika Ltd

Unitil Corp

Unitronix Corp

Unity Bancorp Inc

Unity Biotechnology Inc

Unity Software Inc

WIIM

Korn Ferry shares are trading higher after the company reported better-than-expected Q4 financial results.

PodcastOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODC#NASDAQ">PODC</a>) affirms FY2026 sales outlook from $55.00 million-$60.00 million to $55.00 million-$60.00 million vs $61.01 million estimate.

News

Guidance

PODC

PodcastOne Affirms FY2026 Sales Guidance of $55.00M-$60.00M vs $61.01M Est

Second Patient in first cohort enrolled and treated at the Royal North Shore Hospital/University of Sydney
Aethlon Advances Hemopurifier&#xAE; Study in Solid Tumors Not Responding to Anti-PD-1 Antibodies
SAN DIEGO, June 18, 2025 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4451389-1&amp;h=3638213646&amp;u=https%3A%2F%2Furl.avanan.click%2Fv2%2F___https%3A%2Fwww.aethlonmedical.com%2F___.YXAzOmFldGhsb246YTpvOjhhMGQxZTQ5ODhlNGJjNDNiOTFiOWI3OGQyNTg0NTkyOjY6YjRmZDo1ZDY5N2I5YTA1MGRiODQyMmUyM2NlODE0ODI1OGExZWQzZGVlYzFiODQ3YjNjMmU4YmZjMzY0ZjE1OGJiZmU0OnA6Rg&amp;a=Aethlon+Medical%2C+Inc.">Aethlon Medical, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced a significant milestone: the treatment of the second patient with the&nbsp;Hemopurifier in its Australian safety, feasibility and dose-finding clinical trial of the Hemopurifier. This trial is designed for patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda&#xAE; (pembrolizumab) or Opdivo&#xAE; (nivolumab) (AEMD-2022-06 Hemopurifier Study). The patient was treated with the Hemopurifier June 11, 2025 by Genesis Care and Royal North Shore Hospital/University of Sydney. Professor Stephen Clarke, Medical Oncologist, is the Principal Investigator for the study and the Hemopurifier session was supervised by Dr. Emma O'Lone.
Ongoing progress has been made in our Australian Oncology trial of the Hemopurifier in participants with solid tumors not responding to anti-PD-1 agents. We have now completed Hemopurifier treatments in 2 participants in the first cohort. Our first participant completed the Hemopurifier treatment at Royal Adelaide Hospital on January 29, 2025. Participant # 2 was treated with the Hemopurifier at Royal North Shore/University of Sydney on June 2, 2025. Both participants completed the 4-hour Hemopurifier treatment without device deficiencies or immediate complications. As of June 10, 2025, both patients have completed the pre-specified 7-day safety follow-up period that will be presented to an independent Data Safety Monitoring Board (DSMB) following the treatment of a third patient in the cohort.
The DSMB will review safety data on this first cohort and provide a recommendation to Aethlon Medical Senior Leadership about advancing to the second treatment cohort where 3 participants will receive 2 Hemopurifier treatments during a one-week period. We would expect data on extracellular removal by the Hemopurifier and effects on anti-tumor T cell activity on participants in the first cohort in approximately three months following enrollment of the third patient.

Biotech

General

AEMD

Aethlon Medical Treats Second Patient In Australian Hemopurifier Trial For Solid Tumors Unresponsive To Anti-PD-1 Therapy At Royal North Shore Hospital/University Of Sydney

<h3>Gainers</h3>
<ul>
<li>Lottery.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRY#NASDAQ">LTRY</a>) stock increased by 16.4% to $1.28 during Wednesday's pre-market session. The market value of their outstanding shares is at $34.1 million. </li>
<li>Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) stock rose 15.56% to $1.93. The market value of their outstanding shares is at $37.9 million. </li>
<li>Hour Loop (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOUR#NASDAQ">HOUR</a>) stock moved upwards by 14.98% to $1.4. The market value of their outstanding shares is at $49.0 million. </li>
<li>Full House Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLL#NASDAQ">FLL</a>) shares increased by 10.42% to $3.6. The market value of their outstanding shares is at $129.5 million. </li>
<li>U Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCAR#NASDAQ">UCAR</a>) shares rose 7.33% to $3.95. The company's market cap stands at $17.4 million. </li>
<li>QuantaSing Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSG#NASDAQ">QSG</a>) stock increased by 6.11% to $13.88. The company's market cap stands at $709.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TCTM Kids IT Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSA#NASDAQ">VSA</a>) shares declined by 7.7% to $0.95 during Wednesday's pre-market session. The market value of their outstanding shares is at $9.4 million. </li>
<li>ZHONGCHAO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCMD#NASDAQ">ZCMD</a>) shares decreased by 6.95% to $1.2. The market value of their outstanding shares is at $30.3 million. </li>
<li>SRM Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRM#NASDAQ">SRM</a>) stock decreased by 6.83% to $7.2. The market value of their outstanding shares is at $124.1 million. </li>
<li>Springview Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPHL#NASDAQ">SPHL</a>) stock decreased by 5.82% to $0.52. The market value of their outstanding shares is at $5.9 million. </li>
<li>Vince Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) stock decreased by 5.41% to $1.4. The company's market cap stands at $17.6 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Mixed Martial Arts Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MMA#AMEX">MMA</a>) stock fell 4.77% to $1.0. The market value of their outstanding shares is at $12.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

HOUR

LTRY

SPHL

UCAR

VNCE

ZCMD

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Aptevo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) stock increased by 180.5% to $7.91 during Wednesday's pre-market session. The company's market cap stands at $5.3 million. </li>
<li>Biodexa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>) stock moved upwards by 51.95% to $1.21. The market value of their outstanding shares is at $3.4 million. </li>
<li>Sharps Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) stock increased by 36.12% to $6.82. The company's market cap stands at $6.9 million. </li>
<li>Helius Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) shares increased by 23.48% to $0.38. The market value of their outstanding shares is at $1.2 million. </li>
<li>Senti Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTI#NASDAQ">SNTI</a>) stock increased by 21.94% to $3.39. The company's market cap stands at $88.4 million. </li>
<li>Geovax Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) shares rose 17.82% to $1.06. The market value of their outstanding shares is at $16.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CERo Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) stock declined by 26.8% to $14.52 during Wednesday's pre-market session. The market value of their outstanding shares is at $5.9 million. </li>
<li>Acurx Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACXP#NASDAQ">ACXP</a>) stock fell 22.02% to $0.64. The market value of their outstanding shares is at $15.0 million. </li>
<li>Beyond Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) stock declined by 19.65% to $0.23. The market value of their outstanding shares is at $20.2 million. The company's, Q4 earnings came out yesterday. </li>
<li>Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) stock decreased by 15.07% to $5.92. The market value of their outstanding shares is at $17.0 million. </li>
<li>Citius Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTOR#NASDAQ">CTOR</a>) shares decreased by 13.11% to $1.26. The company's market cap stands at $90.1 million. </li>
<li>Crescent Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBIO#NASDAQ">CBIO</a>) shares declined by 10.78% to $11.84. The company's market cap stands at $230.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACXP

APVO

BDRX

CBIO

CERO

CTOR

EYEN

GOVX

HSDT

SNTI

STSS

XAIR

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Ryde Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RYDE#AMEX">RYDE</a>) stock rose 10.5% to $0.2 during Wednesday's pre-market session. The market value of their outstanding shares is at $5.7 million. </li>
<li>Euroseas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESEA#NASDAQ">ESEA</a>) stock moved upwards by 10.01% to $49.54. The market value of their outstanding shares is at $347.1 million. As per the press release, Q1 earnings came out today. </li>
<li>KULR Technology Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) stock moved upwards by 9.61% to $0.83. The market value of their outstanding shares is at $253.6 million. </li>
<li>Decent Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXST#NASDAQ">DXST</a>) stock rose 9.32% to $1.29. The company's market cap stands at $20.9 million. </li>
<li>Eve Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVEX#NYSE">EVEX</a>) stock moved upwards by 8.88% to $5.88. The market value of their outstanding shares is at $1.7 billion. </li>
<li>Korn Ferry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFY#NYSE">KFY</a>) stock rose 8.59% to $72.5. The company's market cap stands at $3.7 billion. As per the press release, Q4 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CDT Envirn Tech Inv Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTG#NASDAQ">CDTG</a>) shares decreased by 11.2% to $0.93 during Wednesday's pre-market session. The company's market cap stands at $11.4 million. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) stock fell 7.36% to $0.08. The market value of their outstanding shares is at $11.8 million. </li>
<li>3D Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDD#NYSE">DDD</a>) stock fell 6.96% to $1.74. The company's market cap stands at $237.3 million. </li>
<li>Performance Shipping (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSHG#NASDAQ">PSHG</a>) stock decreased by 6.87% to $1.9. The market value of their outstanding shares is at $23.6 million. </li>
<li>Founder Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGL#NASDAQ">FGL</a>) stock decreased by 6.84% to $0.77. The market value of their outstanding shares is at $15.0 million. </li>
<li>Globus Maritime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBS#NASDAQ">GLBS</a>) shares fell 6.72% to $1.25. The market value of their outstanding shares is at $25.7 million. The company's, Q1 earnings came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CDTG

DXST

ESEA

EVEX

GLBS

KULR

PSHG

RYDE

12 Industrials Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Intchains Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICG#NASDAQ">ICG</a>) stock moved upwards by 17.4% to $1.96 during Wednesday's pre-market session. The market value of their outstanding shares is at $118.3 million. </li>
<li>Bit Origin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOG#NASDAQ">BTOG</a>) stock rose 9.41% to $0.18. The company's market cap stands at $10.5 million. </li>
<li>Argo Blockchain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBK#NASDAQ">ARBK</a>) stock moved upwards by 8.63% to $0.41. The market value of their outstanding shares is at $26.0 million. </li>
<li>Cloudastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSAI#NASDAQ">CSAI</a>) stock increased by 8.1% to $2.0. The market value of their outstanding shares is at $33.8 million. </li>
<li>MultiSensor AI Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSAI#NASDAQ">MSAI</a>) stock increased by 7.89% to $0.73. The market value of their outstanding shares is at $24.5 million. </li>
<li>GCT Semiconductor Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCTS#NYSE">GCTS</a>) stock moved upwards by 7.4% to $1.45. The market value of their outstanding shares is at $80.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Trident Digital Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDTH#NASDAQ">TDTH</a>) shares fell 9.4% to $0.25 during Wednesday's pre-market session. The company's market cap stands at $16.3 million. </li>
<li>FiEE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MINM#NASDAQ">MINM</a>) shares declined by 7.14% to $2.58. The market value of their outstanding shares is at $18.9 million. </li>
<li>Bitdeer Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) stock decreased by 6.7% to $11.85. The market value of their outstanding shares is at $2.3 billion. </li>
<li>Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) stock declined by 6.41% to $9.21. The market value of their outstanding shares is at $153.6 million. </li>
<li>T Stamp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDAI#NASDAQ">IDAI</a>) shares fell 5.98% to $1.89. The market value of their outstanding shares is at $4.6 million. </li>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) shares fell 4.93% to $0.88. The company's market cap stands at $22.7 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARBK

BTDR

BTOG

CSAI

GCTS

IDAI

MINM

Infrared Cameras Holdings, Inc. - Common Stock

MSAI

TDTH

12 Information Technology Stocks Moving In Wednesday's Pre-Market Session

PodcastOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODC#NASDAQ">PODC</a>) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.04) by 50 percent. This is a 20 percent decrease over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $14.10 million which beat the analyst consensus estimate of $13.11 million by 7.51 percent. This is a 20.42 percent increase over sales of $11.71 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

PodcastOne Q4 EPS $(0.06) Misses $(0.04) Estimate, Sales $14.10M Beat $13.11M Estimate

IMNN

IMUNON Highlights Presentation Of Translational Data From Phase 2 OVATION 2 Study Of IMNN-001

Houston American Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUSA#NYSE">HUSA</a>) (the "Company") today announced that it has entered into a definitive agreement with an institutional investor (the "SPA") for the purchase and sale of an aggregate of 223,762 shares of common stock (or pre-funded warrants in lieu thereof) at a purchase price of $10.60 per share (or pre-funded warrant in lieu thereof) in a registered direct offering (the "Offering").&nbsp;
The aggregate gross proceeds to the Company of this offering are expected to be approximately $2.37 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The Company currently intends to use the net proceeds of approximately $2.1 million from the offering for general corporate purposes. The transaction is expected to close on or about June 20, 2025, subject to the satisfaction of customary closing conditions.

Offerings

HUSA

Houston American Energy Corp Enters Definitive Agreement For $2.37M Registered Direct Offering Of  223,762 Shares Of Common Stock And Pre-Funded Warrants At $10.60 Per Share To Institutional Investor

Regulatory Approval by the UK Financial Conduct Authority was Key Requirement for Transaction Timing
Minimal Conditions Remain for Deal Completion; Closing Expected in July, 2025
&nbsp;Interactive Strength Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) ("TRNR" or the "Company") today announced that it has received formal approval from the UK Financial Conduct Authority ("FCA") for its previously-announced acquisition of Wattbike, the UK-based, omni-channel, connected, indoor-performance bike business, and that it expects to complete the acquisition in July, 2025.
The FCA's approval satisfies a key condition for the closing of the acquisition, which is expected to significantly expand Interactive Strength Inc.'s presence in the global fitness market, particularly in the UK, and enhance its product offerings with a leading indoor-performance bike offering. This strategic acquisition is anticipated to be immediately accretive to TRNR's results and accelerate growth, especially in key markets like the US and Germany, leveraging TRNR's global distribution network.
Wattbike delivered over $15 million in 2024 revenue and has built on its prestigious elite-sport base - including Olympic teams, Premier League clubs, major US sports teams and elite fitness facilities - to debut a much broader product portfolio that will allow its footprint to scale internationally as well as in the UK, its home market.
"We have been waiting to secure FCA approval in order to finalize the Wattbike deal and now we will push to completion quickly," said Trent Ward, Founder &amp; CEO of Interactive Strength. "This regulatory hurdle was the main closing requirement the timing of which we did not control. The remaining steps are largely administrative. We're already well underway integrating and collaborating with Wattbike, and we look forward to accelerating from here. Wattbike's elite heritage, combined with TRNR's Nasdaq listing, US distribution reach, and marketing muscle, positions us to drive meaningful growth across the UK, US, and Germany."
"We remain thrilled to become part of the TRNR family," added Stephen Loftus, CEO of Wattbike. "With FCA approval secured, we're on the road to fully leverage TRNR's global platform to accelerate our consumer and commercial expansion and bring premium, data-driven indoor cycling to new audiences."
Wattbike is renowned for its high-performance connected indoor bikes, with deep penetration into leading UK gyms and an expanding direct-to-consumer customer base. The acquisition consideration is structured as an all-stock transaction for 100% of Wattbike, and there is an earn-out component to align the business' financial performance with TRNR valuation. Further details regarding the financial impact of the acquisition will be provided in our upcoming filings with the U.S. Securities and Exchange Commission.

TRNR

Interactive Strength Announces It Has Received Formal Approval From The UK Financial Conduct Authority For Previously-Announced Acquisition Of Wattbike And Expects To Complete The Acquisition In July, 2025

Ancora Holdings Group, LLC (together with its affiliates, "Ancora" or "we") today issued the below statement following its decision to redeem its investment in the long-term special purpose vehicle managed by Hestia Capital Management LLC and, in turn, start directly holding its shares of Pitney Bowes Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>) ("Pitney Bowes" or the "Company") due to the size of the position.
Fredrick D. DiSanto, Chairman and Chief Executive Officer of Ancora Holdings Group LLC, and James Chadwick, President of Ancora Alternatives LLC, commented:
"We originally invested in Kurt Wolf's special purpose vehicle because we believed Kurt could be a catalyst of significant value creation at Pitney Bowes. More than two years later, Kurt has clearly been the driving force behind the Company's cost reductions, cash repatriation initiatives, debt reduction and the necessary divestiture of the Global Ecommerce unit. The excellent results speak for themselves. We look forward to remaining long term investors in Pitney Bowes and believe shareholders are well served by Kurt Wolf as the Company's Chief Executive Officer."

Ancora Redeems Investment In Hestia Special Purpose Vehicle, Now Directly Holding Pitney Bowes Shares

STLD

Steel Dynamics Sees Q2 EPS $2.00-$2.04

85% remission rate observed in evaluable frontline AML patients
Mipletamig combination enables rare pathway to transplant in a previously ineligible unfit patient
No dose-limiting toxicities observed among evaluable patients; safety profile remains strong
Evidence mounts for mipletamig as a potentially transformational addition to standard of care in frontline AML as targeted CD123 x CD3 approach showing power and precision, limited added toxicity
Mipletamig Trial Momentum Builds as Cohort 3 Nears Full Enrollment at highest dose level evaluated to date in combination therapy
SEATTLE, WA / <a href="https://www.accessnewswire.com/">ACCESS Newswire</a> / June 18, 2025 / Aptevo Therapeutics ("Aptevo") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>), a clinical-stage biotechnology company developing novel bispecific immuno-oncology therapeutics based on its proprietary ADAPTIR&#xAE; and ADAPTIR-FLEX&#xAE; platform technologies, today announced new clinical data from its ongoing Phase 1b/2 RAINIER trial evaluating mipletamig, its first-in-class CD123 x CD3 bispecific antibody, in combination with standard-of-care venetoclax and azacitidine (ven/aza) for newly diagnosed patients with acute myeloid leukemia (AML) who are unfit for intensive chemotherapy.
Across two trials, the mipletamig triplet therapy delivered remissions in 85% of evaluable frontline AML patients-which significantly exceeds results from competitor studies, including those achieved in the Viale A trial that evaluatedvenetoclax and azacitidine (ven/aza) as doublet therapy. These updated results from the RAINIER dose expansion trial continue to demonstrate a compelling efficacy advantage alongside a strong safety profile. No cytokine release syndrome (CRS) was observed in either cohorts 1 or 2. Cohort 3 Nears Full Enrollment at highest dose level evaluated to date in combination therapy.

Aptevo Therapeutics Reports 85% Remission Rate In Frontline AML With Mipletamig Combination, No Dose-Limiting Toxicities, Enables Transplant In Previously Ineligible Patient; Advances High-Dose Cohort Enrollment In RAINIER Trial

TruGolf Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUG#NASDAQ">TRUG</a>), a leading provider of golf simulator software and hardware, today announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of its Class A common stock. The reverse stock split will take effect at 12:01 am (Eastern Time) on June 23, 2025, and the Company's Class A common stock will open for trading on The Nasdaq Capital Market on June 23, 2025 on a post-split basis, under the existing ticker symbol "TRUG" but with a new CUSIP number 243733409.
As a result of the reverse stock split, every fifty shares of the Company's Class A common stock issued and outstanding prior to the opening of trading on June 23, 2025 will be consolidated into one issued and outstanding share. Proportionate adjustments will be made to the exercise prices and the number of shares underlying the Company's outstanding equity awards, as applicable, as well as to the number of shares issuable under the Company's equity incentive plans. The Class A common stock issued pursuant to the reverse stock split will remain fully paid and non-assessable. The reverse stock split will not affect the number of authorized shares of Class A common stock or the par value of the Class A common stock. No fractional shares will be issued if, as a result of the reverse stock split, a stockholder would become entitled to a fractional share because the number of shares of Class A common stock they hold before the reverse stock split is not evenly divisible by the split ratio. Instead, the stockholder will be entitled to receive a cash payment in lieu of a fractional share.

Comments

Uniti Group

Uniti Group (UNIT) オプション

Uniti Group (NASDAQ:UNIT) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル